Cite
APA Citation
Brener, A., Lebenthal, Y., Interator, H., Horesh, O., Leshem, A., Weintrob, N., Loewenthal, N., Shalitin, S., & Rachmiel, M. (2018). long-term safety of α-1 antitrypsin therapy in children and adolescents with Type 1 diabetes. Immunotherapy, 10, 1137–1148. http://access.bl.uk/ark:/81055/vdc_100160955606.0x00000c